Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABT

Abbott Laboratories

Mar 13 • 04:00PM ET

129.89

Dollar change -0.39
Percentage change -0.30	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ MDT DHR BAX SYK ISRG TDOC BDX RMD ZBH

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IHI VHT

Scroll to Statements

Index	S&P 500	P/E	16.95	EPS (ttm)	7.66	Insider Own	0.67%	Shs Outstand	1.73B	Perf Week	-3.84%
Market Cap	225.27B	Forward P/E	22.76	EPS next Y	5.71	Insider Trans	-7.16%	Shs Float	1.72B	Perf Month	-1.18%
Income	13.35B	PEG	1.60	EPS next Q	1.07	Inst Own	78.80%	Short Float	1.33%	Perf Quarter	13.05%
Sales	41.95B	P/S	5.37	EPS this Y	10.34%	Inst Trans	3.27%	Short Ratio	3.56	Perf Half Y	10.91%
Book/sh	27.52	P/B	4.72	EPS next Y	10.75%	ROA	17.27%	Short Interest	22.93M	Perf Year	8.07%
Cash/sh	4.59	P/C	28.28	EPS next 5Y	10.62%	ROE	30.96%	52W Range	99.71 - 141.23	Perf YTD	14.84%
Dividend Est.	2.37 (1.83%)	P/FCF	35.47	EPS past 5Y	29.98%	ROI	21.82%	52W High	-8.03%	Beta	0.81
Dividend TTM	2.24 (1.72%)	Quick Ratio	1.23	Sales past 5Y	6.15%	Gross Margin	50.90%	52W Low	30.27%	ATR (14)	2.85
Dividend Ex-Date	Apr 15, 2025	Current Ratio	1.67	EPS Y/Y TTM	134.50%	Oper. Margin	16.40%	RSI (14)	44.05	Volatility	2.42% 2.00%
Employees	114000	Debt/Eq	0.32	Sales Y/Y TTM	4.59%	Profit Margin	31.83%	Recom	1.75	Target Price	138.29
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	479.65%	Payout	29.33%	Rel Volume	1.39	Prev Close	130.28
Sales Surprise	-0.52%	EPS Surprise	0.32%	Sales Q/Q	7.16%	Earnings	Jan 22 BMO	Avg Volume	6.45M	Price	129.89
SMA20	-3.48%	SMA50	2.65%	SMA200	12.86%	Trades		Volume	8,985,464	Change	-0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110
Jul-06-22	Initiated	Wolfe Research	Underperform	$95
Mar-02-22	Resumed	BofA Securities	Buy	$140
Jan-27-22	Reiterated	UBS	Buy	$138 → $142
Jan-27-22	Reiterated	Raymond James	Outperform	$150 → $143

Show Previous Ratings

Mar-12-25 06:00PM	Abbott (ABT) Stock Sinks As Market Gains: Here's Why (Zacks)
Mar-11-25 09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-10-25 05:03AM	3 Reasons to Avoid ABT and 1 Stock to Buy Instead (StockStory)
Mar-07-25 08:15AM	2 Dependable Dividend Stocks That Can Pay You for Life (Motley Fool)
05:28AM	Strong Earnings Lift Abbott Laboratories Shares (FX Empire)
05:50PM	Loading…
Mar-05-25 05:50PM	Abbott (ABT) Gains But Lags Market: What You Should Know (Zacks)
Mar-04-25 08:00AM	Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3 LVAD (Business Wire)
06:03AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Feb-28-25 04:04AM	Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest (StockStory)
Feb-27-25 05:50PM	Abbott (ABT) Stock Moves -0.07%: What You Should Know (Zacks)
09:30AM	Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Feb-25-25 09:50AM	Abbott Laboratories: An Exploration into Its Intrinsic Value (GuruFocus.com)
09:00AM	Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
04:02AM	Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment (StockStory)
Feb-24-25 08:35AM	A Brighter Future for Employees With Student Loans (ACCESSWIRE)
04:01AM	Loading…
04:01AM	Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks (StockStory)
Feb-21-25 05:50PM	Abbott (ABT) Gains As Market Dips: What You Should Know (Zacks)
10:48AM	Abbott Declares 405th Consecutive Quarterly Dividend (PR Newswire)
09:35AM	Showing Students the World of Possibilities in STEM (ACCESSWIRE)
Feb-20-25 06:00PM	Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Feb-19-25 02:41AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Feb-17-25 02:47AM	Abbott Laboratories (ABT): Among the Best Drug Stocks to Buy Now (Insider Monkey)
Feb-14-25 01:00PM	If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
Feb-13-25 09:29AM	Jim Cramer on Abbott Laboratories (ABT): Big Position For The Trust (Insider Monkey)
06:35AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. (Motley Fool)
Feb-12-25 09:17AM	Is Abbott Laboratories (ABT) the Best Medical Device Stock to Buy? (Insider Monkey)
Feb-11-25 12:23PM	WHO and St Jude start distributing paediatric cancer medicines amid US aid cuts (Pharmaceutical Technology)
09:00AM	Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know (Zacks)
06:03AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Feb-10-25 08:45AM	How Myths About Diabetes Have a Real Impact on Health (ACCESSWIRE)
04:20AM	Loading…
04:20AM	3 No-Brainer Healthcare Stocks to Buy With $200 Right Now (Motley Fool)
04:04AM	Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX) (StockStory)
Feb-08-25 06:48PM	Jim Cramer on Abbott Laboratories (ABT): This Verdict Is an Outrage Wall Street Agrees? (Insider Monkey)
Feb-07-25 04:56PM	Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility (Investor's Business Daily)
08:45AM	A Powerlifter Overcomes the Weight of Diabetes Stigma (ACCESSWIRE)
Feb-06-25 08:48PM	Jim Cramer on Lawsuit Against Abbott Laboratories (ABT): Dismiss It, Not Worry About It (Insider Monkey)
Feb-04-25 11:27AM	Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care (PR Newswire)
06:02AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Feb-03-25 07:45AM	2 Unstoppable Dividend Stocks That Will Pay You for Life (Motley Fool)
Feb-02-25 04:08PM	Why Abbott Laboratories (ABT) Is Among the Best Cancer Stocks to Buy According to Hedge Funds (Insider Monkey)
Feb-01-25 01:14PM	Musks X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit (The Wall Street Journal)
Jan-31-25 02:42PM	Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates (StockStory)
Jan-29-25 10:15PM	Abbott Laboratories (ABT): How Hot Money Found Its Way Into This Healthcare Giant (Insider Monkey)
11:26AM	Jim Cramer Says Abbott Laboratories (ABT) Was The Market Leader Yesterday. Thats New (Insider Monkey)
Jan-28-25 09:00AM	Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock (Zacks)
06:02AM	The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
Jan-27-25 12:01PM	Abbott Laboratories: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund (GuruFocus.com)
Jan-26-25 01:25PM	Jim Cramer Recommends Abbott Laboratories (ABT) Their Legal Stuff Is Largely Behind Them (Insider Monkey)
Jan-24-25 07:14PM	Analyst Report: Abbott Laboratories (Morningstar Research)
Jan-23-25 07:06AM	Abbott reports Q4 adjusted EPS $1.34, consensus $1.34 (TipRanks)
04:15AM	My Top 5 Stocks to Buy in Early 2025 (Motley Fool)
02:03AM	Abbott Laboratories (ABT) Q4 2024 Earnings Call Highlights: Strong Growth Across Key Segments ... (GuruFocus.com)
01:26AM	Q4 2024 Abbott Laboratories Earnings Call (Thomson Reuters StreetEvents)
Jan-22-25 05:45PM	Analyst Report: Abbott Laboratories (Morningstar Research)
04:03PM	Abbott Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine (Investor's Business Daily)
01:15PM	Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript (Motley Fool)
11:40AM	Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. (Barrons.com)
11:32AM	Abbott Labs misses Q4 sales estimates (Yahoo Finance Video)
11:13AM	Is Abbott Laboratories (ABT) Expected to Post Impressive Earnings This Week? (Insider Monkey)
10:18AM	Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine (Investor's Business Daily)
10:17AM	Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall (Benzinga)
09:30AM	Compared to Estimates, Abbott (ABT) Q4 Earnings: A Look at Key Metrics (Zacks)
08:50AM	Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit (Investor's Business Daily)
08:15AM	Abbott (ABT) Q4 Earnings Meet Estimates (Zacks)
07:12AM	Abbott: Q4 Earnings Snapshot (Associated Press Finance)
07:02AM	Abbott forecasts first-quarter profit below estimates (Reuters)
07:00AM	Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook (PR Newswire)
06:01AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Jan-21-25 07:00PM	P&G earnings, mortgage applications: What to Watch (Yahoo Finance Video)
06:00AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. (Motley Fool)
Jan-19-25 06:21AM	Jim Cramer on Abbott Laboratories (ABT): I Think Abbott Will Win These Baby Formula Cases (Insider Monkey)
05:00AM	What To Expect in the Markets This Week (Investopedia)
Jan-15-25 11:33AM	Jim Cramer on Abbott Laboratories (ABT): Not Understood Very Well Because Theyre Doing Tremendous Stuff When It Comes To Diabetes. People Dont Seem To Care (Insider Monkey)
09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:01AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Jan-13-25 06:00PM	Abbott (ABT) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-08-25 07:16PM	Analyst Report: Abbott Laboratories (Morningstar Research)
06:01AM	Abbott Laboratories: An Exploration into Its Intrinsic Value (GuruFocus.com)
Jan-06-25 06:00PM	Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:38AM	Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy? (Insider Monkey)
09:00AM	LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer (Business Wire)
Jan-03-25 07:36PM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
09:40AM	Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? (Zacks)
Jan-02-25 09:00AM	Abbott Hosts Conference Call for Fourth-Quarter Earnings (PR Newswire)
08:00AM	3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years (Motley Fool)
Jan-01-25 12:45PM	Jim Cramer's Take on Abbott Laboratories (ABT): Bold Predictions for the Future (Insider Monkey)
09:00AM	Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-30-24 06:00PM	Abbott (ABT) Dips More Than Broader Market: What You Should Know (Zacks)
Dec-28-24 06:59AM	Why Is Abbott Laboratories (ABT) Among Diamond Hill Capital's Top Stock Picks? (Insider Monkey)
04:15AM	2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now (Motley Fool)
Dec-25-24 10:15AM	Abbott, DexCom settlement not a complete surprise, says Wells Fargo (TipRanks)
06:01AM	The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
05:30AM	DexCom, Abbott agree to settle patent litigation (TipRanks)
Dec-24-24 05:50PM	Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Dec-23-24 06:00PM	Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Dec-19-24 06:00AM	2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond (Motley Fool)
Dec-18-24 05:15AM	The Smartest Dividend Stocks to Buy With $500 Right Now (Motley Fool)
Dec-17-24 05:50PM	Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
04:03PM	Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta (PR Newswire)
07:00AM	Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart (PR Newswire)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 06 '25	Option Exercise	80.98	91,167	7,382,704	163,095	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 07 '25	Option Exercise	80.98	200	16,196	72,128	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 06 '25	Sale	133.82	91,167	12,199,968	71,928	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 07 '25	Sale	136.65	200	27,329	71,928	Mar 07 06:55 PM
Lisa D. Earnhardt	Officer	Mar 07 '25	Proposed Sale	136.65	200	27,329		Mar 07 06:28 PM
Lisa D. Earnhardt	Officer	Mar 06 '25	Proposed Sale	133.82	91,167	12,199,967		Mar 06 05:47 PM
Wainer Andrea F	RETIRED EVP	Mar 03 '25	Sale	138.17	949	131,123	74,381	Mar 04 08:05 PM
Shroff Eric	Senior Vice President	Mar 03 '25	Sale	138.17	562	77,652	31,970	Mar 04 08:00 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 03 '25	Sale	138.17	1,111	153,507	66,878	Mar 04 07:49 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 03 '25	Sale	138.17	791	109,292	95,583	Mar 04 07:44 PM
MCCOY JOHN A. JR.	VICE PRESIDENT AND CONTROLLER	Mar 03 '25	Sale	138.17	562	77,652	21,061	Mar 04 07:39 PM
Eric Shroff	Officer	Mar 03 '25	Proposed Sale	138.17	562	77,651		Mar 03 08:40 PM
Andrea F. Wainer	Retired Officer	Mar 03 '25	Proposed Sale	138.17	949	131,123		Mar 03 08:18 PM
Louis H. Morrone	Officer	Mar 03 '25	Proposed Sale	138.17	1,111	153,506		Mar 03 08:08 PM
Mary K. Moreland	Officer	Mar 03 '25	Proposed Sale	138.17	791	109,292		Mar 03 07:58 PM
John A. McCoy, Jr.	Officer	Mar 03 '25	Proposed Sale	138.17	562	77,651		Mar 03 07:52 PM
Ford Robert B	CHAIRMAN AND CEO	Feb 05 '25	Option Exercise	38.40	285,388	10,958,899	505,447	Feb 07 05:51 PM
Ford Robert B	CHAIRMAN AND CEO	Feb 05 '25	Sale	131.17	285,388	37,435,200	220,059	Feb 07 05:51 PM
Robert B. Ford	Officer	Feb 05 '25	Proposed Sale	131.17	285,388	37,435,238		Feb 05 06:52 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Option Exercise	38.40	131,360	5,044,224	316,166	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	58,428	2,243,635	243,234	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Sale	128.35	131,360	16,859,675	184,806	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.07	58,428	7,482,629	184,806	Jan 31 07:16 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	23,771	912,806	149,468	Jan 31 07:08 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.50	23,771	3,054,574	125,697	Jan 31 07:08 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Jan 28 '25	Sale	127.39	2,644	336,819	0	Jan 30 07:33 PM
Hubert L. Allen	Officer	Jan 30 '25	Proposed Sale	128.07	58,428	7,482,628		Jan 30 05:33 PM
Daniel Gesua Sive Salvadori	Officer	Jan 30 '25	Proposed Sale	128.50	23,771	3,054,573		Jan 30 05:26 PM
Hubert L. Allen	Officer	Jan 29 '25	Proposed Sale	128.35	131,360	16,859,675		Jan 29 05:30 PM
Funck, Jr. Robert E.	Officer	Nov 04 '24	Proposed Sale	120.00	15,000	1,800,000		Nov 04 04:02 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Option Exercise	47.00	157,421	7,398,787	342,227	Oct 23 05:10 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Sale	117.04	157,421	18,424,298	184,806	Oct 23 05:10 PM
ALLEN HUBERT L	Officer	Oct 21 '24	Proposed Sale	118.89	157,421	18,715,783		Oct 21 04:08 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Option Exercise	47.19	141,679	6,685,975	361,738	Sep 13 05:24 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Sale	116.41	141,679	16,493,218	220,059	Sep 13 05:24 PM
Robert B. Ford	Officer	Sep 12 '24	Proposed Sale	116.41	141,679	16,492,852		Sep 12 06:20 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Sep 04 '24	Sale	114.83	27	3,100	18,681	Sep 04 07:52 PM
Funck, Jr. Robert E.	Officer	Sep 04 '24	Proposed Sale	115.00	30,000	3,450,000		Sep 04 04:04 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Option Exercise	47.00	10,097	474,559	221,438	May 14 05:35 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Sale	104.57	10,097	1,055,819	211,341	May 14 05:35 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	May 07 '24	Sale	106.25	22,852	2,428,119	61,462	May 08 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your FINVIZ experience